April 16, 2021

EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
February 12, 2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.
November 30, 2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

Call for more effective EU regulation of clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
October 19, 2020

Application of the ATMP Hospital Exemption in the EU

EuropaBio and its members would like to engage the European Commission and all relevant stakeholders in a discussion on the future use of the HE in the context of the new EU Pharmaceutical Strategy and its accompanying actions.
March 9, 2020

EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas.
January 15, 2020

What if we could heal sick blood cells

When “adult” blood causes illnesses, rejuvenating blood cells might be a remedy
November 30, 2019

EuropaBio position on Germline Genome Editing

EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet.
February 28, 2019

EuropaBio Advanced Therapy

EuropaBio invites EU decision-makers to engage with us and our healthcare biotech members who are leading the field in advanced therapies.
February 19, 2019

Advanced Medicinal Therapies – Step Up The Healthcare Revolution Now

Read about the outcomes of our working policy breakfast in the European Parliament, hosted by MEPs Claudia Gamon and Tomislav Sokol, in cooperation with ARM, the Alliance for Regenerative Medicine.
September 27, 2017

Joint Press Release on ATMPs and GMOs in Europe

Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
Become a member